BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 33003492)

  • 21. Gene delivery by lentivirus vectors.
    Cockrell AS; Kafri T
    Mol Biotechnol; 2007 Jul; 36(3):184-204. PubMed ID: 17873406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The retroviral vector family: something for everyone.
    Elsner C; Bohne J
    Virus Genes; 2017 Oct; 53(5):714-722. PubMed ID: 28762206
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advances in lentiviral vectors: a patent review.
    Picanco-Castro V; de Sousa Russo-Carbolante EM; Tadeu Covas D
    Recent Pat DNA Gene Seq; 2012 Aug; 6(2):82-90. PubMed ID: 22670608
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-Integrating Lentiviral Vectors in Clinical Applications: A Glance Through.
    Gurumoorthy N; Nordin F; Tye GJ; Wan Kamarul Zaman WS; Ng MH
    Biomedicines; 2022 Jan; 10(1):. PubMed ID: 35052787
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Toward integrase defective lentiviral vectors for genetic immunization.
    Negri DR; Michelini Z; Cara A
    Curr HIV Res; 2010 Jun; 8(4):274-81. PubMed ID: 20353396
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene Therapy Applications of Non-Human Lentiviral Vectors.
    Munis AM
    Viruses; 2020 Sep; 12(10):. PubMed ID: 33003635
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advanced modular self-inactivating lentiviral expression vectors for multigene interventions in mammalian cells and in vivo transduction.
    Mitta B; Rimann M; Ehrengruber MU; Ehrbar M; Djonov V; Kelm J; Fussenegger M
    Nucleic Acids Res; 2002 Nov; 30(21):e113. PubMed ID: 12409472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeted gene modification in mouse ES cells using integrase-defective lentiviral vectors.
    Okada Y; Ueshin Y; Hasuwa H; Takumi K; Okabe M; Ikawa M
    Genesis; 2009 Apr; 47(4):217-23. PubMed ID: 19208434
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The molecular genetics of lentiviral vectors--current and future perspectives.
    Chang LJ; Gay EE
    Curr Gene Ther; 2001 Sep; 1(3):237-51. PubMed ID: 12109139
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genomic insertion of lentiviral DNA circles directed by the yeast Flp recombinase.
    Moldt B; Staunstrup NH; Jakobsen M; Yáñez-Muñoz RJ; Mikkelsen JG
    BMC Biotechnol; 2008 Aug; 8():60. PubMed ID: 18691430
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel integrase-defective lentiviral episomal vectors for gene transfer.
    Vargas J; Gusella GL; Najfeld V; Klotman ME; Cara A
    Hum Gene Ther; 2004 Apr; 15(4):361-72. PubMed ID: 15053861
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nonintegrating lentiviral vectors can effectively deliver ovalbumin antigen for induction of antitumor immunity.
    Hu B; Yang H; Dai B; Tai A; Wang P
    Hum Gene Ther; 2009 Dec; 20(12):1652-64. PubMed ID: 19663564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transgene expression in the mouse cerebellar Purkinje cells with a minimal level of integration using long terminal repeat-modified lentiviral vectors.
    Takayama K; Torashima T
    J Neurovirol; 2009 Sep; 15(5-6):371-9. PubMed ID: 19739019
    [TBL] [Abstract][Full Text] [Related]  

  • 34. RD114 envelope proteins provide an effective and versatile approach to pseudotype lentiviral vectors.
    Bell AJ; Fegen D; Ward M; Bank A
    Exp Biol Med (Maywood); 2010 Oct; 235(10):1269-76. PubMed ID: 20876083
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Strategies for retargeted gene delivery using vectors derived from lentiviruses.
    Bartosch B; Cosset FL
    Curr Gene Ther; 2004 Dec; 4(4):427-43. PubMed ID: 15578992
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Strategies to insulate lentiviral vector-expressed transgenes.
    Ramezani A; Hawley RG
    Methods Mol Biol; 2010; 614():77-100. PubMed ID: 20225037
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histone deacetylase inhibition activates transgene expression from integration-defective lentiviral vectors in dividing and non-dividing cells.
    Pelascini LP; Janssen JM; Gonçalves MA
    Hum Gene Ther; 2013 Jan; 24(1):78-96. PubMed ID: 23140481
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modular Lentiviral Vectors for Highly Efficient Transgene Expression in Resting Immune Cells.
    Fichter C; Aggarwal A; Wong AKH; McAllery S; Mathivanan V; Hao B; MacRae H; Churchill MJ; Gorry PR; Roche M; Gray LR; Turville S
    Viruses; 2021 Jun; 13(6):. PubMed ID: 34207354
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Integrase-deficient lentivirus: opportunities and challenges for human gene therapy.
    Liu KC; Lin BS; Gao AD; Ma HY; Zhao M; Zhang R; Yan HH; Yi XF; Lin SJ; Que JW; Lan XP
    Curr Gene Ther; 2014; 14(5):352-64. PubMed ID: 25174579
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimized Production of Lentiviral Vectors for CAR-T Cell.
    Moço PD; de Abreu Neto MS; Fantacini DMC; Picanço-Castro V
    Methods Mol Biol; 2020; 2086():69-76. PubMed ID: 31707668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.